🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Tulane Cancer Center at Tulane University Hospital and Clinic
Start Date
2001-10
Trial ID
NCT00028860
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
This is a multicenter, randomized, controlled, open-label Phase III clinica...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-06
Trial ID
NCT06792253
Ridaforolimus has been tested in almost 2 dozen studies; however, it has no...
Status
Withdrawn
Location
Cancer Therapy & Research Center at UTHSCSA
Start Date
2011-02
Trial ID
NCT01296659
Treatments Being Tested
The first Part: recruiting untreated ENKL patients with extensive stage I o...
Status
Unknown
Location
Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2015-09
Trial ID
NCT02560441
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1997-09
Trial ID
NCT00003105
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of tisleliz...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-12-14
Trial ID
NCT04486391
Treatments Being Tested
NK malignancies consist of two different clinical entities, extranodal NK/T...
Status
Unknown
Location
The University of Hong Kong
Start Date
2017-07-01
Trial ID
NCT03623087
Treatments Being Tested
This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Status
Unknown
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2022-02-15
Trial ID
NCT05244642
Treatments Being Tested
* Assess responses, progression free survival (PFS) and overall survival (O...
Status
Terminated
Location
National Cancer Centre
Start Date
2011-03
Trial ID
NCT02808091
Treatments Being Tested